CorNeat Vision For Profit
CorNeat Vision leverages synthetic biology to introduce implants that address unresolved ophthalmic challenges in the areas of corneal blindness, ocular trauma, glaucoma, hypotony and epiphora (tearing). As of today, we have successfully developed an artificial cornea and an artificial sclera.
Founded Date:
2015-12-01
Headquarters:
Ra'anana, HaMerkaz, Israel
Technology:
Tissue engineering
Employee Number:
11-50
Industry:
Regenerative Medicine
Estimated Revenue:
$6Mper year